ArticleBritish journal of cancer2021

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance.

Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.